265 Pretargeted nanoparticles to deliver both chemotherapeutics and radiation for the treatment of lymphoma by Fang, C, Jones, J.C, Frayo, S.M, Hylarides, M.H, Zhang, M, Press, O.W

Get full text

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes by Pfeifer, M, Zheng, B, Erdmann, T, Koeppen, H, McCord, R, Grau, M, Staiger, A, Chai, A, Sandmann, T, Madle, H, Dörken, B, Chu, Y-W, Chen, A I, Lebovic, D, Salles, G A, Czuczman, M S, Palanca-Wessels, M C, Press, O W, Advani, R, Morschhauser, F, Cheson, B D, Lenz, P, Ott, G, Polson, A G, Mundt, K E, Lenz, G

Get full text

A multicentre study of primary breast diffuse large B‐cell lymphoma in the rituximab era by Hosein, Peter J., Maragulia, Jocelyn C., Salzberg, Matthew P., Press, Oliver W., Habermann, Thomas M., Vose, Julie M., Bast, Martin, Advani, Ranjana H., Tibshirani, Robert, Evens, Andrew M., Islam, Nahida, Leonard, John P., Martin, Peter, Zelenetz, Andrew D., Lossos, Izidore S.

Get full text

Well-defined single polymer nanoparticles for the antibody-targeted delivery of chemotherapeutic agents by Lane, D D, Chiu, D Y, Su, F Y, Srinivasan, S, Kern, H B, Press, O W, Stayton, P S, Convertine, A J

Get full text

THE 23‐GENE GENE EXPRESSION‐BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL by Scott, D.W., Li, H., Harvey, Y., Chan, F., Mottok, A., Boyle, M., Evens, A.M., Schoder, H., Straus, D.J., Bartlett, N.L., Sweetenham, J.W., Barr, P.M., Fanale, M.A., Hsi, E.D., Cook, J.R., Kahl, B.S., Leonard, J.P., Friedberg, J.W., Leblanc, M., Steidl, C., Gascoyne, R.D., Rimsza, L.M., Press, O.W.

Get full text

Haploidentical Bone Marrow Transplantation Using Anti-CD45 Radioimmunotherapy to Decrease Relapse in a Pre-Clinical Murine Model by Kenoyer, A, Orozco, J.J, Hamlin, D.K, Wilbur, D.S, Fisher, D.R, Hylarides, M.D, Axtman, A, Frayo, S.L, Green, D.J, Gopal, A.K, O'Donnell, P, Press, O.W, Pagel, J.M

Get full text

Comorbidity, Lactate Dehydrogenase (LDH), and Chemosensitivity Are Independent Predictors of Mortality after Autologous Hematopoietic Cell Transplantation (HCT) for Patients (pts)... by Sorror, Mohamed, Storer, B., Gopal, A., Holmberg, L., Sandmaier, B.M., Bensinger, W.I., Maloney, D.G., Press, O.W., Storb, R.F.

Get full text

Non-FcR–binding, humanized anti-CD3 antibody Hu291 induces apoptosis of human T cells more effectively than OKT3 and is immunosuppressive in vivo by Carpenter, P.A, Tso, J.Y, Press, O.W, Yu, X.-Z, Anasetti, C

Get full text

Translocation of Ricin A-chain into Proteoliposomes Reconstituted from Golgi and Endoplasmic Reticulum (∗) by Bilge, Aykut, Warner, Concepcion V., Press, Oliver W.

Get full text

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas by Press, O.W, Appelbaum, F, Martin, P.J, Matthews, D.C, Bernstein, I.D, Eary, J.F, Nelp, W.B, Gooley, T, Glenn, S, Porter, B, Fisher, D.R

Get full text

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes by Pfeifer, M, Zheng, B, Erdmann, T, Koeppen, H, McCord, R, Grau, M, Staiger, A, Chai, A, Sandmann, T, Madle, H, Dorken, B, Chu, Y.-W, Chen, A.I, Lebovic, D, Salles, G.A, Czuczman, M.S, Palanca-Wessels, M.C, Press, O.W, Advani, R, Morschhauser, F, Cheson, B.D, Lenz, P, Ott, G, Polson, A.G, Mundt, K.E, Lenz, G

Get full text

Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes by Pfeifer, M, Zheng, B, Erdmann, T, Koeppen, H, McCord, R, Grau, M, Staiger, A, Chai, A, Sandmann, T, Madle, H, Dorken, B, Chu, Y.-W, Chen, A.I, Lebovic, D, Salles, G.A, Czuczman, M.S, Palanca-Wessels, M.C, Press, O.W, Advani, R, Morschhauser, F, Cheson, B.D, Lenz, P, Ott, G, Polson, A.G, Mundt, K.E, Lenz, G

Get full text